Mark Bodenrader

Mark Bodenrader

Comptroller/Controller/Auditor at CEREVEL THERAPEUTICS HOLDINGS, INC.

Net worth: 749 193 $ as of 30/03/2024

51 year
Health Technology
Finance
Commercial Services

Profile

Presently, Mark Bodenrader is VP-Finance, Chief Financial & Accounting Officer at Cerevel Therapeutics Holdings, Inc.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
18/01/2024 17,724 ( 0.01% ) 749 193 $ 30/03/2024

Mark Bodenrader active positions

CompaniesPositionStart
CEREVEL THERAPEUTICS HOLDINGS, INC. Comptroller/Controller/Auditor 31/08/2019
All active positions of Mark Bodenrader

Former positions of Mark Bodenrader

CompaniesPositionEnd
Corporate Officer/Principal 31/12/2003
Corporate Officer/Principal 31/12/2001
Comptroller/Controller/Auditor -
BIOGEN INC. Comptroller/Controller/Auditor -
See the detail of Mark Bodenrader's experience

Training of Mark Bodenrader

Merrimack College Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Bodenrader's experience

Connections

58

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BIOGEN INC.

Health Technology

CEREVEL THERAPEUTICS HOLDINGS, INC.

Health Technology

Private companies3

Finance

Finance

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Mark Bodenrader